Bristol Myers Squibb (BMY)

EBITDA Margin

39.21%

Quarterly · Period ending:

BMY logo

BMY EBITDA Margin

Latest reported39.21%
BMY Quarterly EBITDA Margin (100.00% → 39.21%)
High-resolution chart · PNG

BMY ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb EBITDA Margin — Quarterly
Period endingEBITDA Margin
35.1455%
38.2811%
37.4582%
37.563%
31.9431%
32.6426%
31.9896%
29.7619%
30.122%
33.8484%
30.4401%
33.208%
29.5711%
32.5461%
28.3495%
32.185%
28.7156%
31.3226%
27.4842%
31.6689%
28.3009%
31.4255%
29.1574%
30.6182%
27.5181%
30.8391%
25.6773%
32.6057%
28.6869%
32.0395%
5.8804%
31.4116%
27.9086%
30.9982%
-7.8661%
28.4563%
25.6944%
29.4646%
21.7569%
30.7943%
27.2894%
28.4826%
19.5175%
29.5957%
26.8116%
26.729%
-243.4746%
100%
100%
100%
-216.6045%
100%
100%
100%
-222.3604%
100%
100%
100%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.